NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 136 filers reported holding NEKTAR THERAPEUTICS in Q2 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,716 | +2.8% | 34,781 | -0.8% | 0.00% | – |
| Q2 2023 | $20,161 | -21.0% | 35,051 | -3.4% | 0.00% | – |
| Q1 2023 | $25,514 | -70.5% | 36,297 | -5.0% | 0.00% | – |
| Q4 2022 | $86,366 | -48.6% | 38,215 | -27.5% | 0.00% | – |
| Q3 2022 | $168,000 | +194.7% | 52,720 | +395.6% | 0.00% | – |
| Q1 2022 | $57,000 | -74.1% | 10,638 | -34.6% | 0.00% | – |
| Q4 2021 | $220,000 | +2.3% | 16,272 | +36.0% | 0.00% | – |
| Q3 2021 | $215,000 | -99.7% | 11,964 | -98.9% | 0.00% | -100.0% |
| Q3 2018 | $67,830,000 | +44.8% | 1,112,700 | +16.0% | 0.03% | +41.7% |
| Q2 2018 | $46,843,000 | -32.7% | 959,300 | +46.4% | 0.02% | -31.4% |
| Q1 2018 | $69,643,000 | +342.3% | 655,400 | -49.8% | 0.04% | +400.0% |
| Q3 2014 | $15,747,000 | -59.6% | 1,304,619 | -57.0% | 0.01% | -58.8% |
| Q2 2014 | $38,930,000 | +5.5% | 3,036,700 | -0.2% | 0.02% | 0.0% |
| Q1 2014 | $36,892,000 | +42.3% | 3,043,900 | +33.3% | 0.02% | +30.8% |
| Q4 2013 | $25,917,000 | +29.7% | 2,283,434 | +19.4% | 0.01% | +18.2% |
| Q3 2013 | $19,978,000 | +39.2% | 1,911,834 | +53.9% | 0.01% | +37.5% |
| Q2 2013 | $14,352,000 | – | 1,242,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |